Xylem (NYSE:XYL) has received various analyst ratings over the last quarter, with 2 bullish, 2 somewhat bullish, and 3 indifferent. No somewhat bearish or bearish ratings were reported. The average 12-month price target for Xylem is $113.43, with a high of $122.00 and a low of $101.00. This target has increased by 1.82% over the past month. Analysts typically rate stocks each quarter based on detailed research and provide guidance on growth estimates, earnings, and revenue.